Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: 514, P. 163426 - 163426
Published: May 5, 2025
Language: Английский
Sleep And Breathing, Journal Year: 2025, Volume and Issue: 29(2)
Published: April 1, 2025
Language: Английский
Citations
0
Nature and Science of Sleep, Journal Year: 2025, Volume and Issue: Volume 17, P. 27 - 42
Published: Jan. 1, 2025
Purpose: We designed a study investigating the cardioprotective role of sleep apnea (SA) in patients with acute myocardial infarction (AMI), focusing on its association infarct size and coronary collateral circulation. Methods: recruited adults AMI, who underwent Level-III SA testing during hospitalization. Delayed-enhancement cardiac magnetic resonance (CMR) imaging was performed to quantify AMI (percent-infarcted myocardium). Rentrop Score quantified collateralization (scores 0– 3, higher scores indicating augmented collaterals). Group differences grade were compared using Wilcoxon Rank-Sum test Fisher's Exact as appropriate, significance threshold set at p < 0.05. Results: Among 33 adults, mean age 54.4± 11.5 BMI 28.4± 5.9. 8 (24%) had no SA, 25 (76%) (mild n=10, moderate n=8, severe n=7). 66% (n=22) CMR, all scores. Median no-SA group 22% versus 28% (p=0.79). While we did not find statistically significant differences, trend toward smaller (median 15.5%; IQR 9.23) other groups (no [22.0%; 16.8,31.8], mild [27%; 23.8,32.5], [34%; 31.53], p=0.12). A proportion > 0, (moderate groups: 62.5% 28%, p=0.08). Conclusion: Our presence collaterals by severity among AMI. However, our results are hypothesis-generating, suggest that may potentially offer benefits through enhanced collaterals. These insights call for future research explore heterogeneity ischemic preconditioning hypoxic burden guide tailored clinical strategies management Keywords: apnea, MI, infarction, MRI, Rentrop,
Language: Английский
Citations
0
European Clinical Respiratory Journal, Journal Year: 2025, Volume and Issue: 12(1)
Published: March 24, 2025
Background Obstructive sleep apnea (OSA) is a common condition affecting around one billion people worldwide. Emerging evidence from recent studies suggests that Glucagon-like peptide 1 receptor (GLP-1) agonists may reduce OSA severity. Hence, this meta-analysis aims to evaluate the efficacy and safety of GLP-1 in patients with OSA.
Language: Английский
Citations
0
Consilium Medicum, Journal Year: 2025, Volume and Issue: 27(01), P. 12 - 17
Published: Jan. 15, 2025
Obstructive sleep apnea (OSA) is one of the most common conditions directly related to and associated with many cardiovascular complications. The prevalence hypertension among patients OSA significantly exceeds that in general population. can both lead occurrence hypertension, complicate its course, cause resistance drug therapy. Also, often leads a change daily blood pressure (BP) profile no physiological decrease or increase during sleep. Physicians should be alert who are snoring experiencing daytime sleepiness, especially if they middle-aged, overweight men. An abnormal diurnal BP and/or resistant multicomponent antihypertensive therapy also indicates probable such patients. diagnosis always confirmed using special instrumental examination methods. effective safe treatment method for clinically significant non-invasive ventilation constant positive airway (CPAP therapy). Proper normalizing profile, decreasing wakefulness, restoring sensitivity
Language: Английский
Citations
0
Sleep Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 106493 - 106493
Published: April 1, 2025
Language: Английский
Citations
0
Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: 514, P. 163426 - 163426
Published: May 5, 2025
Language: Английский
Citations
0